Expand BRTX Menu
BRTX MENU

BRTX Latest Press Releases

-- March 5, 2026 --

BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 Globe Newswire 8:00 AM

-- March 4, 2026 --

BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy Globe Newswire 8:00 AM

-- February 13, 2026 --

BioRestorative Announces Closing of $5.0 Million Public Offering Globe Newswire 8:30 PM

-- February 11, 2026 --

BioRestorative Announces Pricing of $5.0 Million Public Offering Globe Newswire 10:30 PM
BioRestorative Announces Positive Outcome from Type B Meeting with FDA Globe Newswire 7:30 AM

-- February 10, 2026 --

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease Globe Newswire 8:00 AM

-- November 17, 2025 --

BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease Globe Newswire 7:00 AM

-- November 12, 2025 --

BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- November 5, 2025 --

BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 Globe Newswire 4:30 PM

-- October 27, 2025 --

BioRestorative Awarded Notice of Allowance for Japanese Patent - Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market Globe Newswire 7:30 AM

-- October 22, 2025 --

BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio Globe Newswire 9:35 AM

-- October 15, 2025 --

BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit Globe Newswire 9:35 AM
Market Data Delayed 15 Minutes